Elif Burcu Ersungur Çelik

Elif Burcu Ersungur Çelik

Auto-generated profile, based on publicly available information

Elif Burcu Ersungur Çelik

Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2020 in medRxiv
Verified
Preprint
Open access
PDF file
BPBurç Çağrı Poyraz
Burç Çağrı Poyraz
CPCana Aksoy Poyraz
Cana Aksoy Poyraz
ŞTŞenol Turan
Şenol Turan
ÖDÖmer Faruk Demirel
Ömer Faruk Demirel
YKYasin Kavla
Yasin Kavla
EEElif Burcu Ersungur
Elif Burcu Ersungur
We aimed to investigate the effects of COVID-19 outbreak and public health measures on the psychological well-being of patients with psychiatric disorders. This cross-sectional study assessed 436 outpatients recruited from a tertiary psychiatry clinic in Istanbul, Turkey, nearly one month after the government introduced strict measures of lockdown against the ongoing outbreak. Respondents completed a web-based survey on sociodemographic data, subjective sleep quality, and a range of psychiatric symptoms using the Impact of Events Scale-Revised (IES-R), and Hospital Anxiety and Depression Scale (HADS). Respondents reported high frequencies of clinically significant posttraumatic stress disorder (PTSD) (32.6%, IES-R score ≥ 33), anxiety (36.4%, HADS anxiety score > 10), and depression (51%, HADS depression score > 10). 20.5% of respondents described that their psychological status worsened during the COVID-19 outbreak, and 12.1% of respondents described poor or very poor sleep in the prior month. Positive predictors of increased PTSD symptoms included the chronic medical diseases, knowing someone in the social vicinity diagnosed with the COVID-19 infection, job loss or being on temporary leave after the outbreak, and increased exposure time to TV or social media. In contrast, male gender, older age, higher educational attainment, and the psychiatric diagnoses of schizophrenia and (to a lesser degree) bipolar disorder were the negative predictors. Our results suggest that patients with psychiatric disorders are prone to substantial psychological distress during the COVID-19 outbreak, and various individual, behavioral, and social factors mediate this effect.

30 September 2023 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
CPCana Aksoy Poyraz
Cana Aksoy Poyraz
ÖDÖmer Faruk Demi̇rel
Ömer Faruk Demi̇rel
BPBurç Çağrı Poyraz
Burç Çağrı Poyraz
ŞTŞenol Turan
Şenol Turan
EBErsel Bulu
Ersel Bulu
RKRıdvan Karaali̇
Rıdvan Karaali̇
Purpose: Long-lasting COVID-19 symptoms are closely associated with psychiatric sequelae. However, little is known about whether it is possible to predict a protracted course early in the disease. In this study, we aimed to understand how post-COVID-19 psychiatric symptomatology evolves over time and the variables that affect these symptoms. Materials and Methods: Anxiety, depression, acute stress, and sleep disorders among patients with COVID-19 were prospectively evaluated during hospitalization and six months after discharge. Adult patients recently admitted to non-intensive care units with COVID-19 were eligible. Their psychiatric status was assessed using the Hospital Anxiety and Depression Scale, National Stressful Events Survey Acute Stress Disorder Short Scale, Pittsburgh Sleep Quality Index. The patients’ clinical data were gathered from hospital records. Six months after they were discharged, the same questionnaire and a checklist to assess ongoing physical symptoms were distributed to the patients via WhatsApp. Results: 143 participants were enrolled, 47 of whom completed the study. The results showed that patients’ depression, anxiety, and insomnia significantly decreased during the follow-up. However, there was an increase in the number of patients who reported acute stress symptoms. The highest C-reactive protein level during acute infection (OR=1.09) predicted depression during the follow-up. Experiencing a higher number of infectious symptoms during hospitalization predicted a higher number of protracted symptoms six months later (OR=1.5). Conclusion: This indicates that the severity of systemic inflammation during acute COVID-19 infection may predispose patients to persistent depression. Patients with a higher number of symptoms during acute infection may be at risk of developing long-term COVID-19.

30 June 2025 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
CPCana Aksoy Poyraz
Cana Aksoy Poyraz
BBBüşra Uçar Bostan
Büşra Uçar Bostan
EÇElif Burcu Ersungur Çelik
Elif Burcu Ersungur Çelik
IAIrem Hacisalihoglu Aydin
Irem Hacisalihoglu Aydin
MKMehmet Murat Kırpınar
Mehmet Murat Kırpınar
RKRıdvan Karaali
Rıdvan Karaali
Purpose: Following the acute stage of COVID-19, many patients have experienced persistent physical and neuropsychiatric symptoms, regardless of the severity of the illness. Key concerns like fatigue, depressive symptoms, and cognitive impairments have a detrimental effect on psychosocial functioning and quality of life. This study aims to explore cognitive impairments and depression one year after discharge from the hospital for COVID-19, along with implications for quality of life. Materials and Methods: Patients hospitalized with COVID-19 with mild-moderate disease severity were asked to participate in a 12-month follow-up evaluation. A total of 60 individuals who had recovered from COVID-19 were examined for cognitive functions, depressive symptoms, and quality of life. They were then compared to a healthy comparison group, matched for age and education, who had not been infected with COVID-19. Results: After 1 year following discharge, cognitive impairment was noted in 21.7% of COVID-19 patients, based on The Montreal Cognitive Assessment, while only 3.3% of the non-COVID-19 control group exhibited the same. Quality of life domains were largely comparable across groups. Depressive symptoms were identified as the main factor affecting quality of life domains in COVID-19 patients. Conclusion: Despite the potential for cognitive impairment to last for up to a year following hospital discharge, it does not seem to have a negative effect on the quality of life in our group of patients with mild-to-moderate disease severity. However, depressive symptoms were found to be the key indicators of quality of life.

14 October 2026 in Journal of Affective Disorders
Verified
Journal Article
Closed access
EÇElif Burcu Ersungur Çelik
Elif Burcu Ersungur Çelik
BPBurç Çağrı Poyraz
Burç Çağrı Poyraz
SASerdar Arslan
Serdar Arslan
OKOsman Aykan Kargın
Osman Aykan Kargın

30 July 2026 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
EÇElif Burcu Ersungur Çelik
Elif Burcu Ersungur Çelik
CPCana Aksoy Poyraz
Cana Aksoy Poyraz
MKMehmet Murat Kırpınar
Mehmet Murat Kırpınar
ÇKÇağrı Karabacak
Çağrı Karabacak
Objectives: To present a case of catatonia in a patient with schizophrenia successfully managed with clozapine and memantine in the absence of standard treatment options. A focused literature review was also conducted to contextualize the findings within the existing evidence. Methods: A 26-year-old man with schizophrenia presented with classic catatonic symptoms, including mutism, posturing, and negativism. Although a lorazepam challenge confirmed benzodiazepine responsiveness, further use was limited by drug unavailability, and electroconvulsive therapy (ECT) was contraindicated due to a cerebral aneurysm. Clozapine was initiated and titrated to 450 mg/d, followed by adjunctive memantine up to 20 mg/d. Clinical progression was assessed with the Bush-Francis Catatonia Rating Scale (BFCRS). Results: Clozapine treatment led to progressive improvement in motor and verbal functions, followed by accelerated recovery after the addition of memantine. Full remission (BFCRS = 0) was achieved by day 42, with complete functional recovery and sustained stability at the 1-month follow-up. Treatment was well-tolerated without adverse effects. Our focused review of the literature indicated that most reported clozapine-treated catatonia cases involved concomitant benzodiazepines and/or ECT, whereas reports of treatment without these standard interventions were uncommon. Reports describing combined clozapine-memantine treatment were particularly rare. Conclusions: This case demonstrates that clozapine can serve as a viable alternative treatment for catatonia when standard interventions are unavailable or contraindicated. Memantine may offer additional therapeutic benefits; however, further research is required to establish its efficacy. The rarity of similar cases in the literature further highlights the uniqueness of the present clinical scenario.

20 May 2025 in Brain Stimulation
Verified
Journal Article
Open access
BPBurç Çağrı Poyraz
Burç Çağrı Poyraz
EÇElif Burcu Ersungur Çelik
Elif Burcu Ersungur Çelik
AAAli Tarık Altunç
Ali Tarık Altunç
SYSarp Yoldaş
Sarp Yoldaş